nonmyeloablative allogeneic hematopoietic stem cell transplantation [clinicaltrials_resource:7cdb78b43361829f0125b3366eab41a8]
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [clinicaltrials:NCT00295997]Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia [clinicaltrials:NCT00317876]clinicaltrials:NCT00453206Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00454480]Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer [clinicaltrials:NCT00627666]Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [clinicaltrials:NCT00740467]clinicaltrials:NCT00800150Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment [clinicaltrials:NCT00802568]Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease [clinicaltrials:NCT00959231]
intervention [clinicaltrials_vocabulary:intervention]
nonmyeloablative allogeneic hematopoietic stem cell transplantation [clinicaltrials_resource:7cdb78b43361829f0125b3366eab41a8]
Bio2RDF identifier
7cdb78b43361829f0125b3366eab41a8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7cdb78b43361829f0125b3366eab41a8
intervention name [clinicaltrials_vocabulary:intervention-name]
nonmyeloablative allogeneic hematopoietic stem cell transplantation
identifier
clinicaltrials_resource:7cdb78b43361829f0125b3366eab41a8
title
nonmyeloablative allogeneic hematopoietic stem cell transplantation
@en
type
label
nonmyeloablative allogeneic he ...... b78b43361829f0125b3366eab41a8]
@en